REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > O-glycoside > Polysaccharide > Cellulose Or Derivative Cellulose Or DerivativeCellulose Or Derivative patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.02/01/07 - 20070027108 - Method of producing effective bacterial cellulose-containing formulations A new method to produce formulations of bacterial cellulose that exhibit improved viscosity-modifying properties particularly with low energy applied to effectuate viscosity changes therewith is provided. Such a method includes the novel co-precipitation with a water soluble co-agent that permits precipitation in the presence of excess alcohol to form an ... 11/16/06 - 20060258617 - Drug delivery to the back of the eye Disclosed herein are methods of delivering drugs or therapeutically active agents to the back of the eye via topical administration of compositions comprising cyclodextrin derivatives. Compositions related thereto are also disclosed herein. ... 09/21/06 - 20060211654 - Pharmaceutical compositions of cholesteryl ester transfer protein inhibitor A pharmaceutical composition comprises a solid amorphous dispersion of a cholesteryl ester transfer protein inhibitor and a concentration-enhancing polymer. ... 09/07/06 - 20060199784 - Compound selected from sulfated cellulose and salts thereof and dermatitis therapeutic agent The present invention provides a compound selected from sulfated cellulose and salts thereof which can be used as an active ingredient for a cutaneous external preparation produced intending to prevent, soften, improve or cure atopic cutaneous symptoms and the like and which are excellent in a hydrolytic resistance, and dermatitis ... 08/03/06 - 20060172969 - Aqueous pharmaceutical compositions The present invention has an object to provide an antibacterial aqueous pharmaceutical composition and an aqueous pharmaceutical composition which have a sufficiently low gelation temperature even when new quinolone antibacterial agents such as ofloxacin as the active ingredient and can be retained at the administration site for a long time ... 06/22/06 - 20060135472 - Use of water-soluble polymers to improve stability of diiodomethyl-para-tolylsulfone in complex matrices The invention is a method comprising the use of diiodomethyl-para-tolylsulfone with water-soluble polymers, resulting in improved stability of diiodomethyl-para-tolylsulfone in various compositions with complex matrices. In a preferred embodiment of the invention, diiodomethyl-para-tolylsulfone is premixed with a solution of cationic polymer prior to addition to a formulation containing a complex ... 04/06/06 - 20060074053 - Ophthalmic solution containing quinolone antimicrobial compound The present invention provides an ophthalmic solution containing as the active ingredient a quinolone antimicrobial compound, wherein at least one member selected from the group consisting of water-soluble vinyl polymeric compounds and water-soluble cellulose derivatives is formulated into the ophthalmic solution to prevent the quinolone antimicrobial compound from precipitating when ... 03/09/06 - 20060052340 - Ophthalmic solution It is an object of the present invention to provide an ophthalmic solution, which provides an enhanced comfort by suitably exhibiting an moisturizing effect to an eye and advantageously preventing an occurrence of unpleasant feelings caused by fluctuation of visual acuity. The ophthalmic solution of the present invention is provided ... 02/16/06 - 20060035861 - Compositions of polyacids and polyethers and methods for their use as dermal fillers The present invention relates to improved methods for filling the skin for cosmetic or medical purposes. Compositions comprising carboxymethyl cellulose (CMC), polyethylene oxide (PEO) and calcium ions can be made and have physical properties that depend on the amounts and types of CMC, PEO, and calcium ions to form ioniclaly ... 01/19/06 - 20060014721 - Water soluble cellulose etherified derivatives styptic materials The present invention relates to hemostatic materials made of water-soluble cellulose ether derivatives, such as methylcellulose, ethylcellulose, hydroxyethylcellulose, and pharmaceutically acceptable salts of carboxymethylcellulose, especially to hemostatic materials made of water-soluble cellulose ether derivatives capable of being absorbed in live body. The present invention also relates to the use of ... 12/08/05 - 20050272697 - Composition and method for treating post-surgical pain A composition for reducing pain at a surgical wound site or trauma site comprising oxidized regenerated cellulose and a non-steroidal anti-inflammatory drug or pharmaceutically acceptable salt or ester thereof, where the non-steroidal anti-inflammatory drug is an acid having a secondary amine group; and a method of reducing localized pain at ... 11/17/05 - 20050256082 - Allergen inactivator By using such allergen inactivating agent, house dust and other environmental allergens can be inactivated with no adverse effects on the human body and without causing problems such as color development. ... 11/10/05 - 20050250736 - Composition and method for treatment of obesity and smoking cessation The invention involves an instrument of weight loss by means of appetite suppression, along with a method for administering this preparation to humans and other mammals. The preparation consists of a variety of different spices, sweeteners, and salts, as well as proteins and alcohols. Additionally, there is a remedy for ... 11/03/05 - 20050245484 - Lubricious germicidal ophthalmic solutions A novel class of lubricious ophthalmic solutions is formulated to permit the use of a recognized class of demulcents; namely, anionic polymeric demulcents in the presence of a cationic quaternary germicide wherein no precipitation of said germicide occurs. ... 11/03/05 - 20050245483 - Matrix for sustained, invariant and independent release of active compounds The invention concerns a storage stable pharmaceutical formulation comprising preferably two active compounds in a non-swellable diffusion matrix, whereby the compounds are released from the matrix in a sustained, invariant and, if several compounds are present, independent manner and the matrix is determined with respect to its substantial release characteristics ... 10/27/05 - 20050239745 - Novel topical ophthalmic formulations The invention features novel topical formulations of antiallergenic agents in formulation with various other agents (such as a tear substitute) that provide a comfortable formulation when instilled in the eye and has enhanced efficacy and duration of action. The invention further features novel methods of treating ocular allergy by topical ... 10/27/05 - 20050239744 - Method of producing microcrystalline cellulose-containing compositions A novel, environmentally friendly and resource-saving method for the production of fractionally homogeneous compositions of microcrystalline cellulose (MCC) is provided. The method comprises of the following steps: (a) hydrolyzing cellulose-containing raw material with at least one acidic catalyst in the presence of at least one process additive at a low ... 10/20/05 - 20050234016 - Process for the preparation of adsorbates of valsartan and/or its solvates or hydrates The present invention relates to a process for the preparation of adsorbates of valsartan and/or its solvates or hydrates wherein one starts with a solution of valsartan or of one of its pharmaceutically acceptable salts and/or their solvates or hydrates in at least one organic solvent where the total water ... 09/08/05 - 20050197319 - Allergen inactivating agent wherein E1 represents an alkylene containing 1 to 6 carbon atoms optionally substituted with hydroxy group or oxo group; n represents a number of 0 to 50; A independently represents an alkylene containing 1 to 6 carbon atoms, the number of A being n; E2 represents ether bond or oxycarbonyl ... 08/11/05 - 20050176679 - Process for the preparation of free flowing pulverized adsorbates of tibolone The present invention concerns a process for the preparation of adsorbates and solvates of tibolone where one starts with a solution of tibolone or one of its solvates and/or one of its metabolites in at least one organic solvent where the total water content of the solvent is not higher ... 08/04/05 - 20050171056 - Sodium ion absorption inhibitors, and preventive and therapeutic agents and foods containing the same (wherein R represents a cellulose residue and A represents a functional group having cation-exchange ability) ... 07/07/05 - 20050148542 - Intraocular irrigating solution having improved flow characteristics Improved intraocular irrigating solutions are described. The solutions have enhanced viscosities that reduce the risk of damage to intraocular tissues during intraocular surgical procedures by reducing the turbulence of the solutions and dampening the movement of tissue fragments and air bubbles. The solutions preferably also have modified surface tensions that ... ### FreshPatents.com Support |